| Share Name |
Share Symbol |
Market |
Type |
Share ISIN |
Share Description |
| Btg Plc |
LSE:BTG |
London |
Ordinary Share |
GB0001001592 |
ORD 10P |
| |
Price Change |
% Change |
Share Price |
Bid Price |
Offer Price |
High Price |
Low Price |
Open Price |
Shares Traded |
Last Trade |
| |
0.00 |
0.0% |
840.00 |
839.00 |
840.00 |
|
|
- |
0.00 |
00:00:00 |
| Industry Sector |
Turnover (m) |
Profit (m) |
EPS - Basic |
PE Ratio |
Market Cap (m) |
| Support Services |
620.5 |
-70.6 |
3.9 |
215.4 |
3,261 |
Btg Share Discussion Threads
Showing 5901 to 5917 of 6225 messages
| Date | Subject | Author | Discuss |
|---|
11/11/2018
18:11 | What to compare on Tuesday.
4 October 2018 | 09:45am
StockMarketWire.com - Healthcare company BTG guided product sales higher Thursday after including its varicose vein treatment Varithena in its oncology and vascular portfolio.
The company said it expected product sales for the combined portfolio to grow by 15%-to-17% this year, up from its previous forecast of 13%-to-15%.
In pharmaceuticals, following a good first half, BTG said it expected full-year sales to be around the upper end of the guidance range of flat-to-single digit decline.
A better-than-expected first-half performance in pharmaceuticals was driven by DigiFab and Voraxaze, and a good performance from CroFab, BTG said.
First-half product sales growth was driven by 'good' performance in Interventional Medicine led by strong growth in radiotherapy treatment TheraSphere and the cryoablation products, the company said.
Varithena was expected to become profitable during the 2019/20 financial year with sales expected to peak in the high tens of millions of dollars. Varithena sales would be included within the Vascular product sales line going forwards, BTG said.
The company also announced that Chairman Garry Watts was set to retire.
At 9:45am: [LON:BTG] BTG PLC share price was +31p at 590.5p
Story provided by StockMarketWire.com | 
bargainbob | |
11/11/2018
18:06 | Catch me up. What's happening (or not?) | 
waterloo01 | |
11/11/2018
17:08 | Yes , whether we will know who was eyeing us up is another thing . |
bargainbob | |
11/11/2018
17:06 | 7.01 am Tuesday.....the moment of truth! | 
fhmktg | |
10/11/2018
20:48 | Just highest riser of the day : reason momentum continues.
I have a feeling what's happening , as the timeline fits . Good luck all. |
bargainbob | |
10/11/2018
19:15 | Bargain what was the article in daily mail focusing on? | 
dp1umb | |
10/11/2018
14:14 | Mention in mail , momentum continues . |
bargainbob | |
09/11/2018
16:34 | Hope I am wrong but it n the past this shares has risen before results then slipped after. Here's hoping I am wrong as a LTH. | 
bill hunt | |
09/11/2018
16:23 | No need to be careful he a investment fud. |
bargainbob | |
09/11/2018
07:26 | Good news day for
Pharma , back to growth again . |
bargainbob | |
07/11/2018
19:44 | More good trials results.....building nicely towards the results.Hopefully no serious write-downs in the results. |
fhmktg | |
06/11/2018
12:50 | it got new legs . glad i did not short on TW 's tip | 
cannyshoveyergrannyoffthebus | |
06/11/2018
10:28 | It’s not all doom and gloom like some posters would have us believe! |
dp1umb | |
06/11/2018
08:10 | New version of Ekos comes to Europe...spread the news! |
fhmktg | |
01/11/2018
12:11 | no just proving Cokney trader wrong imho.
who has left the building since he was accussed of being Tom W. |
cannyshoveyergrannyoffthebus | |
01/11/2018
11:32 | Is this the traditional run up towards the results, or an early Santa run?Long way to go, but very welcome! |
fhmktg | |
29/10/2018
18:15 | Wow great bounce back. |
bargainbob | |
PLUS1
